This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sk Bioscience Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: YoonJae Lee: Innovator in Vaccine Development
Introduction
YoonJae Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of vaccine development, particularly in the fight against viral infections.
Latest Patents
YoonJae Lee holds a patent for a vaccine composition aimed at the prevention or treatment of SARS-coronavirus-2 infection. This innovative invention includes a recombinant antigen protein that comprises a polypeptide derived from the S1 subunit of the spike protein of SARS-coronavirus-2, along with a polypeptide constituting a tetanus toxin epitope P2 domain. The vaccine composition is designed to enhance immunity against the virus.
Career Highlights
YoonJae Lee is currently associated with SK Bioscience Co., Ltd., a company known for its focus on biopharmaceuticals and vaccine development. His work at the company has positioned him as a key player in advancing public health through innovative vaccine solutions.
Collaborations
He collaborates with notable colleagues such as Ki-weon Seo and Teawoo Kwon, contributing to a dynamic research environment that fosters innovation and development in vaccine technology.
Conclusion
YoonJae Lee's contributions to vaccine development, particularly against SARS-coronavirus-2, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in public health and safety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile